{"id":"https://openalex.org/W1973196042","doi":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","title":"Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children","display_name":"Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children","alternate_titles":[],"publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W1973196042","doi":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","mag":"1973196042","pmid":"https://pubmed.ncbi.nlm.nih.gov/19183418"},"language":"en","primary_location":{"id":"doi:10.1111/j.1398-9995.2008.01890.x","doi":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2008.01890.x","source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973196042"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2008.01890.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001489003","display_name":"Claire Mailhol","orcid":"https://orcid.org/0000-0003-1418-8561","observed_orcids":["https://orcid.org/0000-0003-1418-8561"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Mailhol","raw_affiliation_strings":["Paul Sabatier University and Department of Dermatology, Purpan Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paul Sabatier University and Department of Dermatology, Purpan Hospital, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111808365","display_name":"V. Lauwers\u2010Canc\u00e8s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Lauwers\u2010Cances","raw_affiliation_strings":["Department of Epidemiology and Methodology in Clinical Research, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Methodology in Clinical Research, Toulouse, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020982398","display_name":"Fabienne Ranc\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Ranc\u00e9","raw_affiliation_strings":["Department of Allergology and Pneumology, Toulouse University Paediatric Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Allergology and Pneumology, Toulouse University Paediatric Hospital, Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082011794","display_name":"Carle F. Paul","orcid":"https://orcid.org/0000-0003-0165-5263","observed_orcids":["https://orcid.org/0000-0003-0165-5263"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"C. Paul","raw_affiliation_strings":["Both authors contributed equally to this work","Paul Sabatier University and Department of Dermatology, Purpan Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Both authors contributed equally to this work","institution_ids":[]},{"raw_affiliation_string":"Paul Sabatier University and Department of Dermatology, Purpan Hospital, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4210138343"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113590284","display_name":"Fran\u00e7oise Giordano\u2010Labadie","orcid":"https://orcid.org/0009-0009-6379-9191","observed_orcids":["https://orcid.org/0009-0009-6379-9191"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Giordano\u2010Labadie","raw_affiliation_strings":["Both authors contributed equally to this work","Paul Sabatier University and Department of Dermatology, Purpan Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Both authors contributed equally to this work","institution_ids":[]},{"raw_affiliation_string":"Paul Sabatier University and Department of Dermatology, Purpan Hospital, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4210138343"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5082011794"],"corresponding_institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4210138343"],"apc_list":{"value":5300,"currency":"USD","value_usd":5300},"apc_paid":null,"fwci":13.9539,"has_fulltext":true,"cited_by_count":162,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99428184,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"64","issue":"5","first_page":"801","last_page":"806"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allergic-contact-dermatitis","display_name":"allergic contact dermatitis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.8450000286102295},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.8550000190734863},{"id":"https://openalex.org/keywords/emollients","display_name":"emollients","score":0.800000011920929},{"id":"https://openalex.org/keywords/chlorhexidine","display_name":"chlorhexidine","score":0.953000009059906},{"id":"https://openalex.org/keywords/hexamidine","display_name":"hexamidine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/budesonide","display_name":"budesonide","score":0.8550000190734863},{"id":"https://openalex.org/keywords/tixocortol-pivalate","display_name":"tixocortol pivalate","score":0.9800000190734863},{"id":"https://openalex.org/keywords/bufexamac","display_name":"bufexamac","score":0.9860000014305115},{"id":"https://openalex.org/keywords/sodium-fusidate","display_name":"sodium fusidate","score":0.9829999804496765},{"id":"https://openalex.org/keywords/skin-sensitization","display_name":"skin sensitization","score":0.800000011920929},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.6940000057220459},{"id":"https://openalex.org/keywords/age-of-onset","display_name":"age of onset","score":0.7289999723434448},{"id":"https://openalex.org/keywords/ige-sensitization","display_name":"IgE sensitization","score":0.9300000071525574},{"id":"https://openalex.org/keywords/patch-testing","display_name":"patch testing","score":0.8420000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9060486555099487},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.8520811200141907},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7158926725387573},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.6534401178359985},{"id":"https://openalex.org/C2777697326","wikidata":"https://www.wikidata.org/wiki/Q757678","display_name":"Atopy","level":3,"score":0.5092991590499878},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.491416335105896},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4796224534511566},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.4488426446914673},{"id":"https://openalex.org/C2778091633","wikidata":"https://www.wikidata.org/wiki/Q783903","display_name":"Contact dermatitis","level":3,"score":0.43110841512680054},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.41860800981521606},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31022873520851135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24696707725524902},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000485","descriptor_name":"Allergens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004643","descriptor_name":"Emollients","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004643","descriptor_name":"Emollients","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017449","descriptor_name":"Dermatitis, Allergic Contact","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D017449","descriptor_name":"Dermatitis, Allergic Contact","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017449","descriptor_name":"Dermatitis, Allergic Contact","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1398-9995.2008.01890.x","doi":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2008.01890.x","source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},{"id":"pmid:19183418","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19183418","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1398-9995.2008.01890.x","doi":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1398-9995.2008.01890.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2008.01890.x","source":{"id":"https://openalex.org/S68090385","display_name":"Allergy","issn_l":"0105-4538","issn":["0105-4538","1398-9995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1973196042.pdf","grobid_xml":"https://content.openalex.org/works/W1973196042.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W198427113","https://openalex.org/W1784466401","https://openalex.org/W1790526634","https://openalex.org/W1965673335","https://openalex.org/W1966042513","https://openalex.org/W1969874242","https://openalex.org/W1983657656","https://openalex.org/W1991420824","https://openalex.org/W1995312889","https://openalex.org/W1995854385","https://openalex.org/W2001689549","https://openalex.org/W2017576378","https://openalex.org/W2025667030","https://openalex.org/W2026023228","https://openalex.org/W2043205638","https://openalex.org/W2045968194","https://openalex.org/W2053184959","https://openalex.org/W2055233376","https://openalex.org/W2060693363","https://openalex.org/W2061765860","https://openalex.org/W2074925381","https://openalex.org/W2075221279","https://openalex.org/W2075980344","https://openalex.org/W2164338178","https://openalex.org/W2405195196","https://openalex.org/W2414024065","https://openalex.org/W2416606999","https://openalex.org/W4299585943","https://openalex.org/W4319293042"],"related_works":["https://openalex.org/W2114521794","https://openalex.org/W4323074665","https://openalex.org/W2890613635","https://openalex.org/W1969874242","https://openalex.org/W2026023228","https://openalex.org/W4309658418","https://openalex.org/W4396548469","https://openalex.org/W2413912898","https://openalex.org/W2289593538","https://openalex.org/W2884188896"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1],"is":[2,195,222],"little":[3],"information":[4],"regarding":[5],"the":[6,20,69,74,103,119,172,204,213],"risk":[7,34],"of":[8,22,27,55,86,91,95,105,174,193],"sensitization":[9,23,151,184,228],"associated":[10,36,88,149,196,226],"with":[11,37,46,52,68,150,197,227],"topical":[12,25,57,99,231],"atopic":[13],"dermatitis":[14,221],"(AD)":[15],"treatment.":[16],"OBJECTIVES:":[17],"To":[18],"assess":[19],"frequency":[21],"to":[24,32,98,110,117,152,166,229],"treatment":[26,104,154,192],"AD":[28,47,153,156,169,194,217,230,234,237],"in":[29,102,129,212,216],"children":[30,45,218],"and":[31,43,67,93,112,143,182,201,208,239],"determine":[33],"factors":[35,148,225],"skin":[38],"sensitization.":[39,121,199,241],"METHODS:":[40],"Six":[41],"hundred":[42],"forty-one":[44],"were":[48,79,115,127,134,155],"systematically":[49],"patch":[50,125],"tested":[51],"seven":[53],"agents":[54,100],"common":[56],"treatment:":[58],"chlorhexidine,":[59],"hexamidine,":[60],"budesonide,":[61],"tixocortol":[62,141],"pivalate,":[63],"bufexamac,":[64],"sodium":[65],"fusidate":[66],"current":[70],"emollient":[71],"used":[72,101,116],"by":[73],"child.":[75],"The":[76],"following":[77],"variables":[78],"recorded:":[80],"age,":[81],"sex,":[82],"age":[83,173],"at":[84],"onset":[85,170,238],"AD,":[87,92],"asthma,":[89],"severity":[90,157],"history":[94],"previous":[96],"exposure":[97],"AD.":[106],"Skin":[107],"prick":[108],"tests":[109,126],"inhalant":[111],"food":[113],"allergens":[114],"explore":[118],"IgE-mediated":[120,183,240],"RESULTS:":[122],"Forty-one":[123],"positive":[124],"found":[128],"40":[130],"patients":[131],"(6.2%).":[132],"Allergens":[133],"emollients":[135,202],"(47.5%),":[136],"chlorhexidine":[137],"(42.5%),":[138],"hexamidine":[139],"(7.5%),":[140],"pivalate":[142],"bufexamac":[144],"(2.5%":[145],"each).":[146],"Risk":[147,224],"[OR:":[158],"3.3;":[159],"95%":[160,179,187],"confidence":[161],"interval":[162],"(CI):1.5-7.1":[163],"for":[164],"moderate":[165],"severe":[167],"AD],":[168],"before":[171],"6":[175],"months":[176],"(OR:":[177,185],"2.7;":[178],"CI:":[180,188],"1.2-6.1),":[181],"2.5;":[186],"1.1-5.9).":[189],"CONCLUSIONS:":[190],"Topical":[191],"cutaneous":[198],"Antiseptics":[200],"represent":[203],"most":[205],"frequent":[206],"sensitizers":[207],"may":[209],"be":[210],"included":[211],"standard":[214],"series":[215],"when":[219],"contact":[220],"suspected.":[223],"treatments":[232],"are":[233],"severity,":[235],"early":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973196042","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
